Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Seer (SEER)
NASDAQ:SEER
Holding SEER?
Track your performance easily
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.39Last Year’s EPS
-0.28Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 10, 2021
|% Change Since: 10.63%
|Next Earnings Date:Mar 29, 2021
Earnings Call Sentiment|Neutral
The earnings call highlighted strategic partnerships and a strong cash position, which are positive indicators for future growth. However, the current financial results show a decline in revenue and gross margins, along with a consistent net loss, reflecting ongoing challenges in the market environment.Company Guidance
During the third quarter of 2024, Seer, Inc. provided guidance that anticipates total revenue for the year to range between $13 million and $15 million, reflecting ongoing challenges in the capital expenditure environment. The company reported $4 million in revenue for Q3, a slight decrease from $4.2 million in the same quarter of 2023, mainly due to reduced related party and grant revenues. Despite these challenges, Seer maintains approximately $312 million in cash, cash equivalents, and investments, and a gross margin of 48% for the quarter. Operating expenses totaled $26.3 million, a 6% decrease year-over-year, with R&D and SG&A expenses both showing reductions. Seer also announced a strategic partnership with Thermo Fisher Scientific to expand the market reach of its Proteograph Product Suite, aiming to leverage Thermo Fisher's sales channels starting in early 2025.Partnership with Thermo Fisher Scientific
Seer, Inc. announced a non-exclusive agreement with Thermo Fisher Scientific to co-market and sell the Proteograph Product Suite alongside Thermo's Orbitrap Astral mass spectrometers. This partnership is expected to enhance accessibility to the Proteograph technology for life science researchers globally, starting early 2025.
Strong Cash Position
Seer ended the third quarter with approximately $312 million in cash, cash equivalents, and investments, providing a solid financial foundation for future operations and strategic initiatives.
Strategic Expansion of Seer Technology Access Center (STAC)
Seer launched a second STAC lab in Germany and reported strong demand from European researchers, enhancing access to the Proteograph Product Suite and catalyzing the generation of third-party data and publications.
Increased Academic Interest
Seer noted an increase in academic customers in their pipeline, attributed to growing evidence and publications supporting the Proteograph's value, alongside secured funding for research.
---
SEER Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SEER Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $2.07 | $2.22 | +7.25% |
| Aug 08, 2024 | $1.73 | $1.72 | -0.58% |
| May 08, 2024 | $2.23 | $2.06 | -7.62% |
| Feb 29, 2024 | $1.82 | $1.82 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Seer (SEER) report earnings?
Seer (SEER) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is Seer (SEER) earnings time?
Seer (SEER) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SEER EPS forecast?
SEER EPS forecast for the fiscal quarter 2024 (Q4) is -0.39.
---